• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2024 Scientific Session Call For Abstracts
      • 2024 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Laparoscopic hepatectomy could be the first choice of treatment in selected patients with hepatocellular carcinoma

M Shimada, MD, FACS, S Iwahashi, MD, S Yamada, MD, Y Saitoh, MD, M Kanamoto, MD, Y Arakawa, MD, T Ikemoto, MD, Y Morine, MD, S Imura, MD, T Utsunomia, MD, H Miyake, MD

Department of Surgery, The University of Tokushima

Introduction: Laparoscopic hepatectomy (Lap-Hx) has been established as an important treatment choice for liver tumors, judging from short-term outcome. However, role of Lap-Hx including long-term outcomes remains controversial for hepatocellular carcinoma (HCC). The aim of this study was to clarify usefulness of Lap-Hx for HCC.

Patients and Methods: <Indication> In principle, HCC of more than 10 cm in diameter, with macroscopic vascular invasion, very close to major vessels, is contraindicated for Lap-Hx including a hybrid method. <Patients> Thirty patients with HCC who underwent Lap-Hx were enrolled in this study. Age ranged from 40 to 77 with a median of 63.3, and male:female was 19:11. Tumors were located in the entire liver, and tumor size ranged from 1 cm to 8 cm (median 3.3 cm) in diameter. Operative procedures consisted of right Hx in 1, left Hx in 5, medial segmentectomy in 1, posterior segmentectomy in 1, left lateral segmentectomy in 6, subsegmentectomy in 5, and partial Hx in 11. <Methods> The patients were compared with 30 matched patients who underwent open Hx (Open-Hx), in which the following parameters were matched; liver function, tumor size, tumor location and operative procedure. Both short- and long-term outcomes in Lap-Hx were compared with those in Open-Hx.

Results: No difference was observed between the two groups, in age, gender, viral status, Child-Pugh status, ICGR15, tumor size, and operative procedures. <Short-term outcome> Operative time (291 ± 69 min.) in Lap-Hx was similar to that in Open-Hx (317 ± 76 min.). Blood loss (143 ± 116 ml) in Lap-Hx was smaller than that in Open-Hx (220 ± 166 ml), and hospital stay (15.5 days) in Lap-Hx was shorter than that in Open-Hx (21.4 days). No difference was observed in incidence and kinds of postoperative complications between the two groups. <Long-term outcome> 5-year disease-free survival rate in Lap-Hx tended to be higher than that in Open-Hx (71 % and 52 %), although no difference was observed in 5-year survival rate between the two groups.

Conclusions: Lap-Hx could be the first choice of treatment in selected patients with HCC from the viewpoint of short-and long-term outcomes.


Session: Poster Presentation

Program Number: P320

175

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2013 abstract archive

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064
1-310-437-0544
sagesweb@sages.org
Monday - Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons